Answers are grounded in this paper and cite their sources.
In this issue of Blood, Abel et al designed lentiviral vectors (LVs) enabling specific gene delivery into endothelial cells in vivo. This opens new perspectives for gene therapy of hereditary disorders, cardiovascular diseases, and cancer.
No takes yet. Share an insight, caveat, or question.
VandenDriessche et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: